Day: June 8, 2020

VANCOUVER, Colombie-Britannique, 08 juin 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (« Champignon » ou la « société ») (CSE : SHRM) (FWB : 496) (OTCQB : SHRMF), une société des sciences de l’optimisation humaine mettant l’accent sur la kétamine et la médecine psychédélique, a le plaisir d’annoncer qu’elle a choisi la société torontoise Dalriada Drug Discovery Inc. (« Dalriada ») afin de faire progresser son nouveau portefeuille de PI pour les entités chimiques (« PEC ») en ce qui concerne la kétamine et les échafaudages moléculaires de psilocybine/psilicineDalriada, une importante organisation de recherche contractuelle (ORC) dans le domaine de la découverte de médicaments, dirigera les nouveaux programmes de recherche de médicaments de Champignon dans l’espace des PEC et fournira en outre un soutien en R et D intégré pour faire...

CHARLESTON, S.C., June 08, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ( the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that it has regained compliance with the minimum bid price for continued listing on the Nasdaq Capital Market, as the closing bid price of the Company’s common stock has been at $1.00 or greater for 10 consecutive trading days.On April 8, 2020, the Company received notice that its common stock failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by Nasdaq. Now that the Company has regained compliance with this listing rule, Nasdaq has advised the Company that this matter is now closed.About Aeterna Zentaris Inc.Aeterna Zentaris Inc. is a specialty...

Shenzhen, China, June 08, 2020 (GLOBE NEWSWIRE) — ATIF Holdings Limited (NASDAQ: ATIF), a company providing business consulting services and multimedia services in Asia, today announced that the Company, through Qianhai Asia Time (Shenzhen) International Financial Services Co., Ltd. (“ATIF Shenzhen”), the Company’s variable interest entity in China, entered into a consulting service agreement, dated June 3, 2020 (the “Agreement”), to act as a business advisor for Shenzhen Agrecoe Biotechnology Co., Ltd. (“Agrecoe”), an emerging growth biotechnology company specializing in the research, development, production and sales of microbial inoculants in the three major fields of agriculture, environmental protection and food. The Agreement was signed in anticipation of Agrecoe’s entrance into the U.S. capital market.Pursuant to the Agreement,...

Lenexa, KS, June 08, 2020 (GLOBE NEWSWIRE) — Digital Ally, Inc. (DGLY) (the “Company”), which develops, manufactures and markets advanced video recording products for law enforcement, emergency management, fleet safety and security, today announced the pricing of an underwritten public offering of 2,325,581 shares of its common stock at a price of $2.15 per share, for gross proceeds to the Company of approximately $5 million, before deducting underwriting discounts and other offering expenses. The Company intends to use the net proceeds from this offering for working capital, product development, order fulfillment and for general corporate purposes. The Company priced the offering based on the last closing price.In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 213,953 shares of...

COPENHAGEN, Denmark, June 08, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced presentations related to its rare disease endocrinology programs at ENDO Online 2020, the annual meeting of the Endocine Society, taking place June 8 – 22, 2020.“The fliGHt Trial data presented at ENDO Online demonstrate that subjects taking daily somatropin can safely switch to TransCon hGH, our investigational long-acting prodrug that releases somatropin, with consistent and predictable efficacy,” said Jan Mikkelsen, Ascendis Pharma’s President and CEO. “Further, the interim data from heiGHt Trial subjects who continued in the enliGHten long-term extension trial demonstrated the maintenance of a height advantage...

BOCA RATON, Fla., June 08, 2020 (GLOBE NEWSWIRE) — ADT (NYSE: ADT) announced today that, via ADT Commercial, its commercial channel, it is joining forces with Dollar Tree, Inc. (NASDAQ: DLTR), to help provide protection to its retail locations nationwide. ADT Commercial, a premier provider of commercial security, fire, life safety and risk consulting services in the U.S., will provide comprehensive and innovative security solutions and monitoring services at the majority of Dollar Tree and Family Dollar locations across the U.S.“In these rapidly evolving times, we’re thrilled to be partnering with Dollar Tree for what marks the largest contract to-date for ADT Commercial,” said Jim DeVries, President and CEO of ADT. “Dollar Tree has shown itself to be a true industry leader by seeking out some of the most groundbreaking, enterprise-level...

CAMBRIDGE, Mass., June 08, 2020 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that it will host a conference call and webcast to discuss new clinical efficacy and safety data from the company’s ongoing Phase 2 open-label extension trial of its lead candidate, mavorixafor, in patients with WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome. The data will be presented in an e-poster (Abstract #EP852) at the 25th European Hematology Association (EHA) Annual Congress (“Congress”), taking place virtually from June 11-14, 2020.The X4 Pharmaceuticals conference call and webcast will take place at 8:30 am ET on June 12, 2020. The conference call can be accessed...

SUNNYVALE, Calif., June 08, 2020 (GLOBE NEWSWIRE) — Ooma, Inc., a smart communications platform for businesses and consumers, today announced the appointment of Judi Hand, an experienced cloud services sales and marketing leader, to its board of directors, effective June 3, 2020.Hand is executive vice president and chief revenue officer of TTEC Holdings in Englewood, Colorado, a global customer experience technology and services company serving many of the world’s most iconic and disruptive brands, with 48,700 employees on six continents. With more than 25 years of sales and marketing experience, Hand has held senior positions at telecom industry leaders including AT&T, Northwestern Bell, US West and Qwest.From 2014 to 2017, Hand was an independent board member at Manitoba Telecom Services / Allstream. Hand holds an M.S. degree...

DUBLIN, Ireland, June 08, 2020 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL) a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in patients with narcolepsy, today announced that Greg Divis, Chief Executive Officer of Avadel, and Jordan Dubow, M.D., Chief Medical Officer of Avadel, will present a corporate overview at BIO Digital from June 8-12, 2020.The presentation will focus on the development of once-nightly FT218 and positive results from the Phase 3 Rest-On clinical trial. The presentation will be available on-demand during the conference via https://www.bio.org/events/bio-digital/sessions/693802.About Avadel Pharmaceuticals plc:Avadel Pharmaceuticals plc (Nasdaq: AVDL) is an emerging biopharmaceutical company....

ANN ARBOR, Mich., June 08, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that president and chief executive officer, Tim M. Mayleben, will participate in an analyst-led fireside chat at the Goldman Sachs 41st Annual Global Healthcare Conference on Thursday, June 11, 2020, at 4:40 p.m. Eastern Time.A live audio webcast of this event can be accessed on the investor relations section of the Esperion website at www.esperion.com/investors-media/events-presentations/. Replay of the webcast will be archived on the Company’s website for 90 days following the event.Esperion TherapeuticsThrough scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at Esperion is committed to developing new LDL-C lowering medicines that will make a substantial impact...